Emergent BioSolutions
EBS
#8533
Rank
HK$2.07 B
Marketcap
HK$40.38
Share price
-6.36%
Change (1 day)
-47.56%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: HK$2.07 Billion

As of November 2026 Emergent BioSolutions has a market cap of HK$2.07 Billion. This makes Emergent BioSolutions the world's 8533th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.07 B-59.76%
2025HK$5.15 B48.32%
2024HK$3.47 B257.71%
2023HK$0.97 B-78.87%
2022HK$4.60 B-74.76%
2021HK$18.23 B-50.46%
2020HK$36.81 B69.47%
2019HK$21.72 B-8.6%
2018HK$23.76 B31.2%
2017HK$18.11 B75.65%
2016HK$10.31 B-15.61%
2015HK$12.22 B53.43%
2014HK$7.96 B21.99%
2013HK$6.52 B46.4%
2012HK$4.45 B-5.16%
2011HK$4.70 B-26.43%
2010HK$6.39 B96.75%
2009HK$3.24 B-46.19%
2008HK$6.03 B414.35%
2007HK$1.17 B-51%
2006HK$2.39 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Emergent BioSolutions was reported to be:

HK$2.08 Billion
by Nasdaq info icon info icon
HK$2.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.230 T 59,182.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.567 T 123,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$751.54 B 36,100.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
HK$43.97 M-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$1.49 B-28.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$17.21 B 729.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$352.58 B 16,883.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel